semaglutide and breast cancer Women taking GLP-1 drugs may have lower risk of breast cancer – 95.5 WSB

Can you take Wegovy after breast cancer?

21.66

★★★★☆4.8 (126)

Researchers from Penn Medicine found that women taking GLP-1 drugs are less likely to be diagnosed with breast cancer., @drcelinegounder breaks down the study’s findings and whether the drugs caused

22.89

★★★★★4.9 (98)

In this study, semaglutide decelerated breast cancer appearance, growth and progression. https://lnkd.in/eJVfJY8w

22.68

★★★★★5.0 (157)

GLP-1 Receptor Agonists Show a Striking Signal in Breast Cancer Outcomes, but Big Questions Remain

26.25

★★★★★4.7 (84)

A 30% Risk Reduction Sounds Big. The Actual Numbers Tell a Different Story. A new study says GLP-1 drugs lower breast cancer risk. The real difference? Less than 1%. Read & subscribe (

24.72

★★★★★4.9 (203)

Can Semaglutide Cause Cancer? Know the Potential GLP-1 Risks

24.71

★★★★★5.0 (176)

In a major new JAMA Oncology study, researchers examined health records from 86,632 adults with obesity, comparing those who used GLP-1 receptor agonists (like semaglutide or tirzepatide) to matched non-users. The findings

20.03

★★★★★4.8 (132)